2009-11-16 06:25:23 - Angiotech Pharmaceuticals, Inc. - Medical Equipment - Deals and Alliances Profile - a new market research report on companiesandmarkets.com

www.companiesandmarkets.com/Summary-Company-Profile/angiotech-ph ..

Angiotech Pharmaceuticals, Inc. (Angiotech), is a specialty pharmaceutical and medical device company that discovers, develops and markets technologies primarily focused on acute and surgical applications. The Company generates its revenue through the sales of medical products and components, as well as from royalties derived from sales by its partners of products utilizing certain of its own technologies. The Company operates in two segments: Pharmaceutical Technologies and Medical Products. The Pharmaceuticals Technologies segment includes royalty revenue generated from licensing its paclitaxel technology to various partners. The Medical Products segment manufactures and markets a range of single use, specialty medical devices. The Medical Products segment also manufactures finished medical devices and medical device components for third party medical device manufacturers and marketers.

Angiotech

 

 

Pharmaceuticals, Inc. - Medical Equipment - Deals and Alliances Profile

Summary

Angiotech Pharmaceuticals, Inc. (Angiotech Pharmaceuticals) is a global medical device and specialty pharmaceutical company. The company is engaged in the development, discovery and marketing of medical products and novel technologies for diseases and complications that require medical implants and surgical interventions. It is headquartered in Vancouver, Canada. Recently in March 2009, the company entered into licensing agreement with Baxter International, granting Baxter worldwide rights to COSEAL and certain additional fields of use for COSEAL. In February 2009, the company received license approval for marketing Quill SRS Polydioxanone (PDO), MONODERM and Nylon product lines in Canada.

The Angiotech Pharmaceuticals, Inc. - Medical Equipment - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals.

Scope

- Provides key company information for business intelligence needs
- Gives information on the company’s major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to buy

- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers’ businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors’ business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.